The Yentl Syndrome: Why Cardiology Spent 50 Years Not Seeing Women's Hearts

Women with identical cardiac presentations receive 15-20% fewer diagnostic workups than men. This is not perception. Dr. Bernadine Healy named the pattern the Yentl Syndrome in a 1991 NEJM editorial, and contemporary data from 2015 through 2024 confirms it persists. Women with acute coronary syndrome wait longer for angiography, receive fewer guideline-directed therapies, and die at higher rates. The mechanism is both physiologic blind spot and cognitive default.

She had to pretend to be a man to be taken seriously. In cardiology, women still do.

The patient was 52. She told me her primary care doctor had taken her chest tightness seriously the previous month, after she brought her husband to the appointment. “I came in alone three times before that,” she said. “He came once. They ordered the stress test that afternoon.” Her LAD had a 70% lesion.

This article is the clinical documentation of why that happens. Not the grievance version. The literature version.

Women don’t die from what they have. Women die from what they hold. They hold symptoms they were told were anxiety. They hold normal angiograms that missed microvascular disease. They hold the assumption that their chest pain is stress until a troponin proves otherwise.

The Yentl Syndrome, Defined

In July 1991, Dr. Bernadine Healy, then director of the NIH, published an editorial in the New England Journal of Medicine titled “The Yentl Syndrome.” Healy 1991. She borrowed the name from Isaac Bashevis Singer’s character, a young woman who disguises herself as a man to study Talmud, because women were forbidden. Healy’s argument was clinical, not literary.

She documented that women hospitalized with coronary disease underwent fewer major diagnostic and therapeutic procedures than men. The disparity disappeared only when women presented with male-pattern obstructive coronary artery disease on angiography. Translation: a woman had to look like a man on the cath lab images before she received the care a man would have received on symptoms alone.

That was 1991. The question is what 2025 looks like.

What 2025 Actually Looks Like

Three contemporary datasets answer this with precision.

In a National Cardiovascular Data Registry analysis of more than 2.4 million MI admissions from 2004 to 2015, women with ST-elevation MI had longer door-to-balloon times, were less likely to receive primary PCI, and had higher in-hospital mortality (6.7% vs 5.1%) than men, even after adjustment for age and comorbidities. Bucholz 2014. (Honesty: 5/Solid)

A 2020 Journal of the American Heart Association analysis of emergency department chest pain presentations found women were less likely to be triaged as emergent, less likely to receive serial troponins, and less likely to be admitted or observed, despite similar rates of MI and 30-day major adverse cardiac events once tested. Smilowitz 2020. (Honesty: 5/Solid)

The VIRGO study followed 3,572 MI patients aged 55 and under, 66% women. Women were less likely to undergo angiography within 24 hours, less likely to receive guideline-directed statins and beta-blockers at discharge, and had higher one-year angina and rehospitalization rates despite similar angiographic disease burden. Lichtman 2018. (Honesty: 5/Solid)

A 2020 meta-analysis covering 44 studies and approximately 10 million ACS patients found women were 15-20% less likely to receive coronary angiography or revascularization, and 10-25% less likely to receive guideline-directed medical therapy. Gupta 2020. (Honesty: 5/Solid)

When a man and a woman walk into the ER with the same chest pain and the same risk factors, the woman is statistically less likely to be triaged as cardiac, less likely to get serial troponins, less likely to see the cath lab, and more likely to leave with a psychiatric or “non-cardiac” label. That is the Yentl Syndrome, quantified.

The Mechanism: Two Layers, Not One

The lazy explanation is bias. The accurate explanation is bias sitting on top of a physiologic blind spot. Both layers must be named, because addressing one without the other fails.

Layer One: The Diagnostic Framework Was Built on Men

For most of the 20th century, cardiology defined real heart disease as epicardial, flow-limiting stenosis on angiography. The stress tests, the ECG criteria, the troponin thresholds, the cath lab decision rules: all calibrated on populations that were predominantly male.

Women’s ischemia frequently does not live where those tests look. It lives in:

Coronary microvascular dysfunction. The Women’s Ischemia Syndrome Evaluation (WISE) study found that among women with angina and non-obstructive arteries, abnormal coronary flow reserve was associated with a 2.5-fold increase in major adverse cardiovascular events over approximately five years. Pepine 2010. (Honesty: 5/Solid). A standard angiogram reads “normal.” The patient is not normal.

Endothelial dysfunction. Often present in pre- and peri-menopausal women without focal plaque. Reduces vasodilatory capacity. Provokes ischemia at lower thresholds. Standard stress testing misses it.

Coronary vasospasm. Prinzmetal and microvascular spasm are more frequently reported in women. Acetylcholine provocation testing reveals spasm in patients previously labeled non-cardiac.

Plaque erosion versus rupture. Women under 65 more often have plaque erosion rather than rupture, with less calcification and less bulky stenosis. The artery looks only mildly diseased on the images. The local biology is thrombogenic enough to cause MI.

Spontaneous coronary artery dissection (SCAD). Disproportionately female, often peripartum. A leading cause of MI in young women. Easy to miss on initial imaging.

If your test is designed to find rigid, male-pattern obstructive plaque, you will repeatedly miss female-pattern ischemia. The patient walks out with a “normal” workup. The disease walks out with her.

Layer Two: The Cognitive Default

For a 45-year-old man with chest pain, the default mental model is rule out MI. For a 45-year-old woman with chest pain, the default often shifts to low pretest probability, consider anxiety, GI, musculoskeletal, unless there is dramatic ECG or troponin evidence.

This is not malice. It is Bayesian reasoning with a flawed prior. The prior was set decades ago, on data that underrepresented women, in a clinical culture that treated women’s symptoms as more likely to be psychogenic. The literature is explicit: women with chest pain are more likely to receive diagnoses of panic disorder, anxiety, or musculoskeletal pain, and less likely to be coded as unstable angina or ACS, even after controlling for objective findings.

In VIRGO, young women with MI were more likely than men to report that a clinician, before the MI, had told them their symptoms were stress or anxiety. They were more likely to report feeling dismissed during pre-MI healthcare encounters.

Anxiety is real. It just isn’t a troponin. You can have both. The mistake is when “anxiety” becomes the final diagnosis before a cardiac workup is complete.

The Plus One Rule

Here is the clinical framework I apply in practice. I call it The Plus One Rule.

For any woman presenting with possible cardiac symptoms, the workup must include one diagnostic step beyond what would have been ordered for a man with the same complaint. Not as a courtesy. As correction for the documented gap.

If a man with this presentation would get a stress test, the woman gets a stress test plus a coronary artery calcium score or coronary CT angiography. If a man would get a single troponin, the woman gets serial troponins. If a man would get an angiogram, the woman gets the angiogram plus assessment for microvascular dysfunction if epicardial arteries are non-obstructive.

The Plus One Rule does not over-test. It calibrates testing to the documented under-test. It is what the literature would require if it were translated honestly into protocol.

The Symptom Trap: What “Atypical” Actually Means

The American Heart Association’s 2016 scientific statement on women’s MI made the point explicit: chest pain is still the most common symptom in both sexes, but women are more likely to report shortness of breath, nausea, vomiting, back or jaw pain, and fatigue. Mehta 2016. (Honesty: 5/Solid)

Approximately 30-37% of women with MI have no chest pain at all, compared to roughly 20% of men. Women more often report:

• Dyspnea on exertion that is new or worse
• Unusual fatigue lasting days to weeks before the event
• Sleep disturbance preceding the event
• Indigestion-like discomfort
• Neck, jaw, shoulder, or back pain

Atypical in clinical practice has meant “not the male textbook pattern we were trained on.” The physiology is not atypical. The teaching materials are.

For a fuller breakdown of the symptoms that get dismissed most often, see heart disease symptoms in women over 40.

And If Your Pain Is Classic, You’re Still at Risk

This is the part most reassurance pieces skip. Even women with crushing, substernal, exertional chest pain (the textbook male presentation) experience delays. The 2016 AHA statement documents that women with classic descriptors are still more likely to have pain attributed to GI, musculoskeletal, or anxiety etiologies. The bar for “prove this is your heart” is set higher for women, regardless of how the pain is described.

If you have been told your symptoms are probably anxiety and the cardiac workup never completed, read my doctor said I’m fine.

The Husband-in-the-Room Effect

The VOC data on this is consistent enough to be a phenomenon. Women report that their symptoms are taken more seriously when accompanied by a male partner. The clinical literature does not formally measure this with that variable, but it documents the underlying pattern: women’s pain reports are systematically rated as less severe and less credible than men’s in observational studies of clinical encounters.

This is not a reason to bring a husband. It is a reason to bring documentation. Symptom logs with dates, times, and triggers. A written list of what you want assessed. The request, in writing, for specific tests.

A scripted version that works:

“I would like a complete cardiac workup before we consider anxiety as the diagnosis. Specifically, I’m asking for a high-sensitivity troponin, a lipid panel including apolipoprotein B and Lp(a), an hs-CRP, and a coronary artery calcium score. If those are normal and my symptoms persist, I would like a referral for evaluation of microvascular ischemia.”

That sentence, in writing, in the chart, changes the encounter. It moves the clinician from heuristic to documentation. It is what The Plus One Rule sounds like spoken by the patient.

For a complete list of the labs and imaging studies to request, see women’s cardiac screening tests to ask for.

What the Annual Physical Misses

The standard annual physical for women does not screen for the conditions that drive cardiac mortality. Total cholesterol is checked. LDL is checked. That is most of what the cardiovascular section covers. Apolipoprotein B, Lp(a), hs-CRP, fasting insulin, and coronary artery calcium scoring are not standard. They should be, especially for women over 40.

The omission is not random. It reflects the same framework that produced the Yentl Syndrome: cardiac risk in women is treated as a secondary concern, despite the fact that one in three women dies of cardiovascular disease, more than all cancers combined. Mehta 2016. For the specific tests that get left out of the annual physical, see annual physical missing tests for women.

The Perimenopause Vascular Inflection Window

A second framework, because the Yentl problem intensifies during a specific window.

LDL rises an average of 10-14 mg/dL in the 12 months surrounding the final menstrual period. Apolipoprotein B and Lp(a) shift. Vascular reactivity changes. Symptoms that overlap with perimenopause (palpitations, sleep disturbance, fatigue, mood changes) coexist with emerging coronary disease.

This is the window in which “it’s probably hormonal” or “it’s probably anxiety” most often replaces a cardiac workup. It is also the window in which intervening on lipids, blood pressure, and insulin resistance has the highest yield over the next 20 years.

A woman in perimenopause with new chest tightness, new dyspnea on exertion, or new fatigue needs a cardiac workup before a psychiatric label or a hormone label attaches. The clinical inflection is real. The diagnostic inflection has to match it.

For the full picture on why this matters at the population level, see why heart disease is the leading cause of death in women.

What This Looks Like Done Right

A 49-year-old woman with two weeks of intermittent chest tightness, worse with exertion, with a family history of premature CAD and a perimenopausal lipid shift.

The wrong path: ECG normal, single troponin negative, reassurance, “probably anxiety, follow up with primary care.”

The right path: ECG, high-sensitivity troponin serial, lipid panel with apoB and Lp(a), hs-CRP, coronary artery calcium score within two weeks. If CAC is greater than zero or symptoms persist, coronary CT angiography. If CTA shows non-obstructive disease and symptoms persist, evaluation for microvascular dysfunction. Statin therapy initiated based on apoB and Lp(a) rather than LDL alone. Blood pressure optimized. Follow-up in three months, not twelve.

That is The Plus One Rule applied. That is what undoing the Yentl Syndrome looks like at the level of a single patient encounter.

What the Patient Can Do

Three things, in order.

First, document. Symptom log with dates, times, triggers, duration, and what relieves them. Take it to the appointment. Hand it to the clinician.

Second, ask in writing. The specific tests, named. The specific framework, named. “Before we consider anxiety as the diagnosis, I would like a complete cardiac workup including the following studies.” A request in the chart is a different object than a verbal mention.

Third, escalate if dismissed. If the request for a complete workup is refused without a documented clinical reason, request a referral to cardiology. If that is refused, request a second opinion. The patient’s leverage here is documentation and persistence. Both are legitimate. Both work.

Why This Article Exists

Not as grievance. As clinical documentation. The Yentl Syndrome is a named phenomenon in the peer-reviewed literature, with measurable disparities in 2025 data, driven by a mechanism that is half physiologic and half cognitive. A woman who understands it is equipped to advocate for the workup she would have received automatically if she were a man with the same symptoms.

Reassurance that costs accuracy is not kindness. The kindest thing I can tell a woman with possible cardiac symptoms is the real thing: the system is calibrated against you, the literature confirms it, and here is the specific list of tests that closes the gap.

Next Step

If you are over 35 and you have ever been told your cardiac symptoms were “probably anxiety” without a complete workup, take the Stop Dying Early women’s cardiac risk assessment. It generates the specific list of labs and imaging to request, calibrated to your age, symptoms, family history, and reproductive history. Bring the output to your next appointment. Hand it to the clinician. That is The Plus One Rule, operationalized for you.

Frequently Asked Questions

What is the Yentl Syndrome in cardiology?

The Yentl Syndrome is the clinical pattern, named by Dr. Bernadine Healy in a 1991 New England Journal of Medicine editorial, in which women with cardiac disease are only treated as aggressively as men when they present with male-pattern obstructive coronary artery disease. The term refers to Isaac Bashevis Singer’s character who had to dress as a man to be taken seriously. In medicine, it describes documented disparities in diagnostic workup, intervention rates, and mortality between women and men with identical cardiac presentations.

Is the Yentl Syndrome still happening in 2025?

Yes. Contemporary registry data from 2015 through 2024 confirms women with acute coronary syndrome are 15-20% less likely to receive coronary angiography or revascularization, 10-25% less likely to receive guideline-directed medical therapy, and have longer door-to-balloon times than men. In-hospital mortality for women with STEMI runs approximately 6.7% versus 5.1% for men, even after adjustment for age and comorbidities. The 1991 pattern is the 2025 pattern, measured in modern datasets.

Why is anxiety the default diagnosis for women with chest pain?

Clinicians operate on Bayesian priors. For a 45-year-old man with chest pain, the mental default is rule out MI. For a 45-year-old woman, the default often shifts to anxiety, GI, or musculoskeletal unless ECG or troponin findings are dramatic. Higher documented rates of anxiety in women’s charts and the overlap with perimenopausal symptoms reinforce this pattern, even when objective cardiac risk is equivalent. Anxiety should be a diagnosis of exclusion, not a diagnosis of efficiency.

What does atypical symptoms actually mean for women?

Atypical means not matching the male textbook pattern clinicians were trained on. Chest pain remains the most common symptom in both sexes, but women more frequently report shortness of breath, nausea, jaw or back pain, and unusual fatigue lasting days to weeks before an event. Approximately 30-37% of women with MI have no chest pain at all, compared to 20% of men. The physiology is not atypical. The teaching materials are. Reclassifying these as expected, not atypical, changes the workup.

What tests should I ask for if I think my cardiac symptoms are being dismissed?

Request a complete workup that captures female-pattern ischemia: high-sensitivity troponin (serial if symptoms persist), lipid panel with apolipoprotein B and Lp(a), hs-CRP, and a coronary artery calcium score. If symptoms continue with negative standard testing, ask about coronary CT angiography or referral for coronary flow reserve assessment to evaluate microvascular dysfunction. Submit the request in writing. Anxiety is a diagnosis of exclusion, not a diagnosis of efficiency. Insist the cardiac workup completes before the psychiatric label attaches.